Netupitant/Palonosetron Hydrochloride and Dexamethasone With or Without Prochlorperazine or Olanzapine in Improving Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer
Condition: Breast Carcinoma Interventions: Drug: Dexamethasone; Other: Laboratory Biomarker Analysis; Drug: Netupitant/Palonosetron Hydrochloride; Drug: Olanzapine; Other: Placebo; Drug: Prochlorperazine; Other: Quality-of-Life Assessment Sponsors: Gary Morrow; National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Aloxi | Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Dexamethasone | Prochlorperazine | Zyprexa